InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,703.86
(
-0.10%
)
US TECH 100
19,313.60
(
0.18%
)
Dow Jones
42,049.83
(
-0.35%
)
Brent Oil
77.39
(
3.72%
)
Bitcoin
60,251.14
(
-0.61%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

walldiver

Send PM Follow Ignore
Followers 24
Posts 1614
Boards Moderated 0
Alias Born 01/02/2003

walldiver

Re: henrylucas post# 2102

Thursday, 02/22/2007 2:46:16 PM

Thursday, February 22, 2007 2:46:16 PM

Post# of 12660
Similar to yours, Henry. It was an incremental positive. I think that of the remaining data issues that have not yet been released, the biggest potential positive for the Provenge BLA would be the 9902A cause-specific mortality data. If it's as good or almost as good as the CSM data for 9901, then 9902A becomes much more supportive in my view, and probably from the view of the FDA biostatisticians as well...but you can bet they would go over it with a fine-toothed comb.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up